Sort by Expiration Date:
Filter:

Online Programs

Sort by Expiration Date:
Filter:

What Can You Do to Improve Clinical Outcomes for Your Patients with Viral Influenza at High-Risk for Pulmonary Complications?

This virtual satellite symposium discusses best practices for managing people with influenza who are at high risk for developing pulmonary complications. 2D animation technology is incorporated throughout the program to highlight the mechanism of action of point-of-care tests (POCTs) and antiviral treatments approved for treatment. Clinical data supporting the efficacy of antivirals and guidance on their use will also be provided.

Learn More & View Event »

Parkinson’s Disease Psychosis is Often Underdiagnosed and Undertreated: What Can You Do to Improve the Quality of Care for Your Patients?

In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.

Learn More & View Event »

Atopic Dermatitis: Targeting Underlying Inflammatory Pathways with Systemic Therapy – THE THRIVE INITIATIVE

Upon the completion of this program, attendees should be able to:

  • Apply up-to-date guidance on the initiation and use of systemic immunosuppressants and immunomodulators in patients with atopic dermatitis during the COVID-19 pandemic
  • Assess the severity of atopic dermatitis and select appropriate treatment options for patients who require intensified therapy
  • Review the mechanism of action, efficacy and safety of systemic treatments for atopic dermatitis in pediatric and adult patients
Learn More & View Event »

Leveraging Novel Treatment Options for Small-Cell Lung Cancer in the Second Line

This enduring virtual TeleECHO program will explore the management of small cell lung cancer (SCLC) in the second-line setting. A brief didactic presentation will discuss treatment options after relapse of SCLC and will assess clinical trial data regarding the efficacy and safety of second-line treatment regimens. Interactive case studies will illustrate the application of guideline recommendations for treatments approved for managing extensive-stage SCLC.

Learn More & View Event »

Parkinson’s Disease Psychosis is Often Underdiagnosed and Undertreated: What Can You Do to Improve the Quality of Care for Your Patients?

In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.

Learn More & View Event »

Advances in the Therapeutic Management of Patients with Chronic Hematological Conditions – A Whiteboard Preceptorship

Recent advances in treatment strategies promise to improve the lives of patients with sickle cell disease or hemophilia. In this program, experts in both fields will assist clinicians in developing individualized management plans using state-of-the-art and emerging therapies, and highlight opportunities to implement multidisciplinary, patient-centered approaches to care. Case studies and interactive question and answers will provide learners practice in applying patient-specific factors to treatment decisions. This activity will feature whiteboard animations that will reinforce learning and help participants gain a higher level of understanding.

Learn More & View Event »

Understanding Cervical Biology and Oncogenesis: Leveraging Checkpoint Inhibition in Recurrent and Metastatic Disease

This case-based online activity will help gynecologists and medical oncologists improve the timeliness of screening for women at risk for cervical cancer and the accuracy of diagnosis; and recognize the limitations of currently available regimens for recurrent and metastatic disease. The education will also seek to expand awareness of the integral role that the immune system plays in the pathology of cervical cancer and how IO agents in late-stage development for patients with recurrent or metastatic cervical cancer potentially could be integrated into practice once available.

Learn More & View Event »

A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies

  • Select therapies for the improvement of glycemic and extra-glycemic outcomes in patients with T2DM.
  • Determine the rationale for targeting GIP and GLP-1 receptors in the treatment of type2 diabetes and its metabolic comorbidities.
  • Identify patients in their own practice who may potentially benefit from treatments targeting GIP and GLP-1 receptors in the future based on knowledge of recent clinical data
Learn More & View Event »

Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes

  • Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
  • Identify patients with type 2 diabetes who are most likely to benefit from the use of GLP-1 receptor agonists
  • Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
  • Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM
Learn More & View Event »

Going Beyond the Classic Management of Cutaneous Squamous Cell Carcinoma: Anti-PD1 Therapy

  • Discuss the elements of immune dysfunction that drive the tumorigenesis of cutaneous squamous cell carcinoma (cSCC)
  • Review risk stratification of patients with cutaneous squamous cell carcinoma to determine who are at high risk of recurrence
  • Describe the application of medical practice guidelines and supporting trial data to the treatment of patients with locally advanced and metastatic cSCC
Learn More & View Event »

Prurigo Nodularis: Therapeutic Possibilities

  • Develop treatment regimens that address the immunological and neural components of prurigo nodularis (PN)
  • Integrate patient-specific factors, such as quality of life and comorbidities, into the selection of treatment options for the management of PN
  • Assess clinical trial data on the efficacy and safety of emerging therapies for the treatment of PN
Learn More & View Event »

Assessing Severity of Alopecia Areata and Understanding the Role of Novel Systemic Therapies

This activity provides a practice-based learning experience for dermatologist and primary care physicians regarding the assessment and treatment of alopecia areata (AA). By participating in this Simulation Center, learners will observe an interaction between a physician and their patient with AA and will test their knowledge of diagnosis and management at key decision points along the way. The burden of AA and its associated comorbidities will be highlighted, and you will learn strategies to effectively address the psychosocial impacts of this disease with your patients.

Learn More & View Event »

Assessing the Growing Evidence in Alopecia Areata: The Role of JAK Inhibitors

This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations and case studies.

Learn More & View Event »

Improving SMBG Skills – The Power is in Their Hands: The Role of Diabetes Self-Management Education and Support in Patients Receiving Insulin

This activity will help participants to overcome clinical inertia and other potential barriers to timely and appropriate insulin therapy in patients with type 2 diabetes. Participants will be equipped with an enhanced ability to select, titrate and adjust basal insulin regimens, and to successfully educate and empower their patients to self-manage their diabetes.

Learn More & View Event »

Managing the Older Adult with T2DM: The Role of Fixed-Ratio GLP-1 Receptor Agonist/Insulin Combinations

This CME activity will help participants identify the characteristics of older adults with type 2 diabetes that require special consideration, assess older patients with type 2 diabetes, and develop personalized pharmacotherapeutic strategies for older patients with type 2 diabetes, both in the community and in long-term care, that include the use of fixed-ratio GLP-1 receptor agonist/insulin combinations. The activity features a Situation Room, a unique online program which employs a patient simulation platform. The situation room provides interactive quizzing, testing, and training via immersion-focused 3D simulations of scenarios encountered by clinicians who care for older adults with type 2 diabetes. The experience will be customized based on who is using the simulation. One track will be aimed at geriatricians and endocrinologists, and the other will be aimed at PCPs, physician extenders and consultant pharmacists. A slide presentation will guide the learners in their selection of treatment strategies.

Learn More & View Event »

New Treatments Bring New Challenges: Can You Identify and Mitigate Therapy-related Adverse Events Associated with the Use of Immuno-oncology/Tyrosine Kinase Inhibitor Combination Therapies?

  • Interpret data from studies exploring the safety/toxicity profiles of IO/TKI combination therapies used to treat patients with advanced solid tumors
  • Develop strategies to manage the irAEs and trAEs associated IO/TKI combination therapies used for the treatment of patients with advanced solid tumors
  • Support multidisciplinary team approaches for the diagnosis and management of irAEs in patients with advanced solid tumors treated with combination IO/TKI therapies
Learn More & View Event »

The CATALYST Initiative: Expanding Knowledge to Improve Clinical Decision-Making and Health Outcomes for Patients with Hematologic Malignancies: A Focus on CLL

This case-based enduring activity is designed to help community oncologists and the multidisciplinary care team choose the optimal treatment for chronic lymphocytic leukemia (CLL) based on patient and disease characteristics, including performance status, organ function, comorbidities, drug interactions, and genetic and molecular biomarkers; monitor for and manage adverse events; and implement SDM into clinical practice to improve patient care and QoL.

Learn More & View Event »

Immuno-oncology Therapies for the Treatment of Advanced Endometrial Cancer: Which of Your Patients May Benefit from Their Use?

This enduring TeleECHO program will explore the management of patients with advanced endometrial cancer through interactive case studies. Faculty will review strategies on personalizing the selection of treatment options based on molecular testing and discuss the management of adverse events with immune-oncology/tyrosine kinase inhibitor combination therapies.

Learn More & View Event »

Assessing the Growing Evidence in Alopecia Areata:
The Role of JAK Inhibitors

This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations, case presentations, and a pre-recorded Q&A session.

Learn More & View Event »

Atopic Dermatitis: Managing the Burden of Moderate-to-Severe Disease and Its Associated Comorbidities

This activity will explore the management of pediatric and adult patients with moderate-to-severe atopic dermatitis through interactive case-based simulations. Expert faculty will review strategies on how to personalize the selection of systemic treatment options based on guideline recommendations, evidence-based best practice, and emerging clinical trial data. Case-based simulations will help learners identify candidates for systemic therapy and address safety and quality of life issues.

Learn More & View Event »

Exploring Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Diagnostic Best Practices and Considerations in Addressing Underlying Inflammation

This enduring program is designed for allergists, otolaryngologists, primary care clinicians, and other clinical team members who manage chronic rhinosinusitis with nasal polyps. In this program, we will aim to discuss the burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach clinicians how to apply best practices for the interdisciplinary development of individualized treatment plans for these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach clinicians who manage this condition.

Learn More & View Event »

Optimizing the Care of Patients with Moderate-to-Severe Asthma: Minimizing Asthma Exacerbations with Biologic Therapy

This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.

Learn More & View Event »

Evaluating and Managing Ocular Toxicities and Other Potential Adverse Events in the Management of Relapsed/Refractory Multiple Myeloma

This enduring TeleECHO program will explore the management of ocular toxicities and other adverse events related to treatment of relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss how and why these adverse events occur. The importance of Risk Evaluation and Mitigation Strategy (REMS) programs for monitoring your patients for corneal changes and other effects of later-line therapy for multiple myeloma will also be presented. Interactive case studies will illustrate strategies for choosing therapy and for managing treatment-related adverse events in the RRMM setting.

Learn More & View Event »

Advances in the Treatment of Patients with Systemic Lupus Erythematosus: Leveraging its Pathogenic Pathways to Improve Outcomes

  • Describe the immune cells and proinflammatory proteins that represent therapeutic targets in SLE including BAFF, type 1 interferon, and cytokines associated with JAK/STAT signaling
  • Explain how dysregulated innate and adaptive immune responses lead to specific clinical manifestations and disease consequences in patients with SLE
  • Evaluate the safety and efficacy of new and emerging SLE therapies that target its pathogenetic pathways
  • Select treatments for patients with SLE based on their pathogenic rationale

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

Learn More & View Event »

Disease Modification in Individuals with Moderate-to-Severe Rheumatoid Arthritis: Optimizing Treatment Through the Finely Tuned Selectivity for JAKs

This enduring TeleECHO activity will explore the use of JAK inhibitors for the management of rheumatoid arthritis (RA) through interactive case studies. Faculty will review emerging efficacy and safety data, discuss guideline recommended care of RA, and help clinicians identify candidates for treatment with JAK inhibitors.

Learn More & View Event »

Therapeutic Options in Hepatorenal Syndrome with Acute Kidney Injury: Confirming the Value of Systemic Vasoconstriction

This enduring activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of hepatorenal syndrome with acute kidney injury (HRS-AKI), impacting outcomes through diagnosis and differentiation from other forms of AKI as well as individualizing pharmacotherapeutic management.

  • By addressing these gaps, you can assess whether your approach to HRS-AKI diagnosis and management through utilization of the latest clinical trial data on emerging pharmacotherapies – could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying challenges to HRS-AKI diagnosis and staging, the evolution of pharmacotherapies in HRS-AKI, and relevant clinical considerations to their application in case management.
  • You will also be immersed in interactive, animated simulation case studies to memorably highlight key points related to assessment and treatment options in HRS-AKI.

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs
When Should You Use Monoclonal Antibodies in Pediatric Patients?

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

In this episode, a pediatric infectious disease specialist will clarify when to use monoclonal antibodies in pediatric patients with COVID-19 and discuss ways to overcome challenges in administering therapy.

Learn More & View Event »

New Strategies for Reducing Cardiovascular Risk in CKD with T2D: Development of Finer Mineralocorticoid Antagonists

In this comprehensive and interactive CME activity, we will be presenting important topics in the area of diabetic kidney disease. The program includes slide-based material interspersed with interactive questions and case studies to enhance learning. The focus is on kidney disease in the diabetic patient, specifically mechanisms of disease, diagnosis and evaluation, and therapeutic options.

Learn More & View Event »

Worldwide Strategies for the Management of BCC and cSCC: Can Immunotherapies Provide Effective Treatment for Your Patients with Non-Melanoma Skin Cancers?

This interactive global educational activity is designed to help oncologists, pathologists, surgeons, dermatologists, and other healthcare practitioners who care for patients with advanced or metastatic basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC) to improve their knowledge of the disease, best practices for treatment, and the role of immunotherapy in managing non-melanoma skin cancer (NMSC).

Learn More & View Event »

Clinical and Managed Care Considerations in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Considerations in Addressing Underlying Inflammation

In this program; we will aim to discuss the cost burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach pharmacists how to apply best practices within the framework of interdisciplinary managed care of these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach pharmacists who see this condition.

Learn More & View Event »

Evaluating Treatment Selections for Chronic Spontaneous Urticaria: Managed Care Considerations

This enduring MedGames is an interactive gamification-style CME activity that covers important topics in chronic spontaneous urticaria (CSU). The educational format of this program is engaging and covers the economic and physiological burden of CSU, diagnostic algorithms, guideline recommended step-care management, and efficacy and safety of current and emerging biologic therapy.

Learn More & View Event »

Project ECHO: HR+/HER2- Metastatic Breast Cancer: What Can You Do to Optimize Patient Access to Cyclin-dependent Kinase 4 and 6 Inhibitors? – An Innovative View

This enduring TeleECHO educational series targets healthcare gaps related to the familiarity and understanding of CDK4/6 inhibitor clinical trial designs and results on efficacy, safety, and real-world studies, impacting outcomes through current practice patterns and treatment strategies in the management of HR+/HER2- metastatic breast cancer (mBC).

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

In this episode, an emergency medicine physician will discuss strategies for the administration of monoclonal antibodies in adult and pediatric patients in an emergency department setting.

Learn More & View Event »

A Nurses’ Perspective: Oral Therapies in Breast Cancer: Considerations for Enhanced Adherence in the Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer

Oncology nurses are in an inherently valuable position to be in the frontline of breast cancer treatment for patients. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience. 

Learn More & View Event »

The RELIEF Initiative: Reducing the Burden of Axial Spondyloarthritis Through Screening and Referral

This live virtual activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.

Learn More & View Event »

The RELIEF Initiative: Reducing the Burden of Axial Spondyloarthritis Through Screening and Referral

This enduring activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.

Learn More & View Event »

Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: Understanding Current First-line Strategies

This activity provides a practice-based learning experience for medical oncologists, pulmonologists, nurse practitioners, and other health care providers, regarding the assessment and treatment of non-small cell lung cancer (NSCLC) in the first-line setting. By participating in this Simulation Center, learners will observe an interaction between a patient with NSCLC and their healthcare provider, and will test their knowledge of diagnosis and management at key decision points along the way.

Learn More & View Event »

Clearing the Air on Modern Pneumococcal Vaccination Strategies: Improving Population Outcomes and Simplifying Complex Recommendations in Managed Care

Pneumococcal disease caused by Streptococcus pneumoniae is the leading cause of pneumonia-related deaths and poses an important global public health concern. There are several vaccines available for prevention of this disease, but their implementation in the clinic is challenged by complex recommendations of their administration for various patient populations and by complicated guidelines for appropriate spacing and sequencing of vaccine schedules. Managed Care Specialists need to understand the nuances of pneumococcal vaccines to guide physicians on their appropriate use to reduce infections and improve clinical outcomes, particularly for at-risk patients. This educational activity will explore the impact of pneumococcal disease, pathophysiology of disease, guidelines recommendations, and strategies for managing vaccine hesitancy. In addition to a didactic presentation, the program features animations and case discussions to highlight the different aspects of this disease.

Learn More & View Event »

Novel Mechanisms and Emerging Agents for Anemia of CKD: Best Practices for Evidence-Based Care Across Specialties

This online activity with an integrated case-based learning component will enable clinicians to recognize emerging targets in the management of anemia of chronic kidney disease (CKD) through an understanding of the underlying pathophysiology and clinical trials evaluating novel therapies. By integrating these data with the current standards of care in the management of anemia of CKD, clinicians will be better able to understand the role of multiple healthcare professionals in the management of this common complication of CKD. Additionally, the integrated case-based activity within this program will ensure that healthcare professionals can readily translate learnings to patient interactions, ensuring that patients and the healthcare team are aware fully aware of emerging therapeutic alternatives.

Learn More & View Event »

Preventing Structural Damage in Psoriatic Arthritis: A New Domain

Through a series of informative lectures and podcast interviews, this educational series will target clinicians in the field of rheumatology who have patients with psoriatic arthritis. We will provide the latest information on clinical presentation, differential diagnosis, therapeutic targets, and clinical trial data on current and emerging therapies to help learners reduce both short- and long-term consequences of the disease.

Learn More & View Event »

Considerations in the Evaluation of Real-World Evidence for Patients with Multiple Myeloma: Efficacy and Safety Considerations to Inform Therapy

This enduring TeleECHO program will explore the role of real-world evidence in informing management decisions of elderly and frail patients with relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss prognostic features and key management considerations for the elderly and frail patient populations. A summary of clinical trial data and real world evidence to inform treatment selection in the first-line and relapse settings will also be presented. Interactive case studies will illustrate strategies for patient counseling and treatment selection in elderly and frail patients with RRMM.

Learn More & View Event »

The Challenges Presented by Hypertrophic Cardiomyopathy in Clinical Practice: How Does Your Approach Compare with the Experts’?

This interactive online activity will explore the diagnosis and management of hypertrophic cardiomyopathy (HCM). A didactic presentation by expert faculty will review guideline recommendations and risk factors for complications, discuss pharmacologic and surgical treatment options, and examine clinical trial data on emerging agents. An animated case will allow learners to apply what they have learned in a simulated clinical encounter.

Learn More & View Event »

Insights in Acute Myeloid Leukemia: Optimizing System Level Quality for Our Veterans

This activity will explore the management of patients with of newly diagnosed and relapsed/refractory acute myeloid leukemia (AML). This program will address the role of genetic and molecular markers in treatment selection as well as best practices for treatment of newly diagnosed, and relapsed/refractory, and secondary AML. A summary of approaches to TRAE recognition and mitigation will also be discussed.

Learn More & View Event »

The Evolution of Incretin Therapy: The Potential Role of GIP/GLP-1 Receptor Agonists in Treating Patients with Obesity and T2DM

This CME program has been designed for endocrinologists who treat patients with type 2 diabetes. It aims to help learners evaluate the impact of weight loss and timely treatment intensification in patients with T2DM on glycemic and metabolic outcomes, and to increase knowledge of the mechanism of emerging GIP/GLP-1 receptor agonists and their impact on glycemic outcomes and body weight in order to advantageously integrate them into clinical practice when available.

Learn More & View Event »

Why Weight? Obesity Management as a Treatment Goal for Patients with Type 2 Diabetes

This CME program has been designed to provide participants with the knowledge necessary to simultaneously address weight management and glycemic control in patients with type 2 diabetes and obesity/overweight. Participants will gain a greater understanding of guidelines-recommended pharmaceutical and lifestyle management strategies, and learn how incretin therapies with beneficial impacts on glycemic outcomes and body weight can be integrated into clinical practice. In addition to viewing a faculty presentation of relevant clinical data and guidelines, learners will participate in Med Games, an engaging gamified learning activity featuring interactive quizzes and video case studies that provide the opportunity to make decisions about patient care and get immediate feedback.

Learn More & View Event »

PARP Inhibitor–based Combinations for the Management of Patients with Metastatic Castration-resistant Prostate Cancer: What Are the Data Telling Us?

This enduring activity has been designed for HCPs treating metastatic castration-resistant prostate cancer (mCRPC) to improve: knowledge of the mechanisms of action of PARP inhibitor–based combinations for the treatment of patients with mCRPC with or without DNA damage response (DDR) alterations; awareness of new clinical data on the efficacy, safety, and tolerability of emerging PARP inhibitor–based combinations with different mechanisms of action for the treatment of patients with mCRPC; and their ability to develop individualized management plans for patients with mCRPC with or without DDR alterations that include PARP inhibitor–based combinations if appropriate.

Learn More & View Event »

Reducing the Burden and Cost of Chronic Spontaneous Urticaria

This enduring MedGames is an interactive gamification-style CME activity that covers important topics in chronic spontaneous urticaria (CSU). The educational format of this program is engaging and covers the economic and physiological burden of CSU, diagnostic algorithms, guideline-recommended step-care management, and efficacy and safety of current and emerging biologic therapy.

Learn More & View Event »

Treating COVID-19 Based on Disease Severity: Key Considerations in Hospitalized Patients

In this educational activity, expert faculty will discuss the use of approved and authorized treatments for the management of patients hospitalized with COVID-19. A review of clinical trial data on the efficacy and safety of therapeutic options and strategies for selecting therapy based on disease severity and clinical factors will allow clinicians to reduce the need for invasive ventilation and improve patient outcomes.

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

Learn More & View Event »

Nontuberculous Mycobacterial Lung Disease (NTM-LD): Overcoming Common Pitfalls in Diagnosis and Treatment

This enduring activity will explore the diagnosis and management of NTM-LD. Whiteboard animations will identify common pitfalls that lead to delays in diagnosis and look at the mechanism of action of novel therapies for refractory disease. A case-based didactic lecture led by expert faculty will review guideline-recommended care, strategies to minimize adverse events, and clinical trial data on newer treatment options.

Learn More & View Event »

Improving Outcomes in Pediatric and Adult Patients with Eosinophilic Esophagitis Through Earlier Diagnosis and Treatment

This case-based enduring activity will focus on the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis (EoE). Patients with EoE are often diagnosed after symptom onset, leading to greater chronic inflammation, and treatment plans are frequently not tailored to individual needs. This activity is intended to help healthcare professionals diagnose EoE earlier and provide individualized treatment based on guidelines, recent clinical data and patient characteristics.

Learn More & View Event »

Treating COVID-19 Based on Disease Severity: Key Considerations in Hospitalized Patients

This educational activity will review clinical trial data on the use of authorized therapies for the management of patients hospitalized with COVID-19 and explore strategies to incorporate these therapeutic options into clinical practice. This program includes a whiteboard animation on the role of inflammation in the pathophysiology of severe COVID-19 and the mechanism of action of available treatment options.

Learn More & View Event »

A Patient-Centered Approach to Concussion Care for Emergency Medicine and Primary Care Physicians

This online activity has been designed for primary care, emergency care, sports neurologists, headache neurologists, and other healthcare professionals involved in the management of people with acute and chronic post-concussion symptoms to help them in evaluating and treating patients by using a patient-centered approach. This activity includes a personal interview featuring a patient who has experienced concussion and is now living with post-concussion syndrome.

Learn More & View Event »

Modifying Chronic Kidney Disease Risk in Patients With Type 2 Diabetes: Opportunities and Robust Data With Mineralocorticoid Antagonists

This enduring activity is designed to review the importance of chronic kidney disease (CKD) risk reduction in patients with T2D, how to evaluate opportunities to screen for CKD risk in patients with T2D and target reductions in albuminuria, the manageability of hyperkalemia and uniqueness of novel therapy, and key takeaways and practice changes.

Learn More & View Event »

Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy

This enduring activity will focus on the latest updates in the optimal management of cancer-associated venous thromboembolism (VTE) based on risk stratification, clinical trial data, and appropriate guideline-informed strategies to optimize clinical outcomes. This program will inform participants of the latest best practices as recommended by professional guidelines and will equip participants to integrate multidisciplinary care and shared decision-making in practice.

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

In this episode, an emergency nurse will review how to administer monoclonal antibodies in patients with COVID-19 and best practices for monitoring for adverse reactions.

Learn More & View Event »

A Closer Look at Evolving Treatment Strategies in Rheumatology: Exploring Best Practices for the Timely Diagnosis and Management of RA, PsA, AxSpA and JIA

This educational activity will explore best practices for the management of rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and juvenile idiopathic arthritis (JIA). Expert faculty will review the latest information on clinical presentation, treatment recommendations, and clinical trial data on available therapies to help learners reduce both short- and long-term consequences of disease. An innovative simulation center will allow clinicians to apply what they have learned in an interactive, animated case.

Learn More & View Event »

Applying Evidence-Based Therapy Through Oncology Nursing That Maximizes HER2-Targeted Efficacy While Enhancing Tolerability

Oncology nurses are in an inherently valuable position to be in the frontline for treatment of HER2-positive solid tumors. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience. For additional resources, please visit www.oncologynurse-ce.com.

Learn More & View Event »

Optimizing Patient Outcomes in Gaucher Disease:
Evaluating the Latest Enzyme Replacement Therapies

This online activity is designed to increase HCPs recognition of metabolic pathways involved in the pathophysiology of Gaucher disease; confidence discussing clinical trial data supporting improved outcomes in Gaucher disease; understanding of the potential for treatment to modify outcomes in Gaucher disease; and understanding of shared decision-making best practices for long-term management of Gaucher disease.

Learn More & View Event »

Advances in Atopic Dermatitis: The Emerging Role of JAK Inhibitors for Moderate-to-Severe Disease

This enduring activity has been designed to help dermatologists, pediatric dermatologists, primary care physicians, advanced practice providers (NPs and PAs) and other healthcare providers who are involved in the care and treatment of patients with atopic dermatitis to assess patients for physical and psychosocial burdens of AD; identify candidates for systemic therapies; better evaluate recent clinical trial data on the efficacy and safety of JAK inhibitors for the management of moderate-to-severe AD; and apply evidence-based approaches to manage moderate-to-severe AD and monitor for adverse events.

Learn More & View Event »

Approaches to Improving Care in Chronic Lymphocytic Leukemia in the Veteran’s Affairs System: Insights from the Experts

This activity will explore the management of patients with of treatment-naïve and relapsed/refractory chronic lymphocytic leukemia (CLL). This program will address approaches to individualize selection of therapy and the role of minimal residual disease (MRD) in monitoring treatment effectiveness. A summary of approaches to TRAE recognition and mitigation will also be addressed.

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

Learn More & View Event »

Novel Therapeutic Perspectives in the Management of DLBCL: The Role of Antibody-Drug Conjugates and Bispecific Antibodies

This Community Whiteboard ECHO Series and Online Enduring activity is designed to increase the multi-disciplinary oncology care team recognition of the role of targeted and bispecific antibodies in management of relapsed/refractory DLBCL; strengthen their understanding of clinical trial outcomes and adverse events with targeted and bispecific antibodies; and improve their awareness of multidisciplinary best practices for managing adverse events from targeted therapies.

Learn More & View Event »

Emphasizing the Diabetes Care Team in the Diagnosis and Management of Diabetic Retinopathy

This online program targets critical issues in diabetic retinopathy, including the importance of screening and early detection of retinopathy, how early treatment in retinopathy can help prevent progression to vision-threatening complications, and the advantageous impact of multidisciplinary management in the care of a retinopathy patient. Learn essential elements of screening, referral, and treatment, as well as core systemic factors affecting risk for both development and worsening of diabetic eye disease, which when optimized can help preserve vision in diabetes.

Learn More & View Event »

Beyond Conventional Anti-VEGF Therapy:
Reducing the Burden of Treatment and Improving Outcomes in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

This case-based online activity is designed for retina specialists, ophthalmologists, primary care providers, optometrists, and other healthcare providers who manage patients with neovascular age-related macular degeneration and/or diabetic macular edema. The activity aims to improve treatment for patients who do not achieve optimal outcomes due to insufficient responses to therapy or insufficient adherence. In addition, it will elucidate the benefits and limitations of current therapeutic approaches, equip participants with strategies for improving the durability of treatment response in patients receiving intravitreal therapies, and provide education on new and emerging treatment strategies.

Learn More & View Event »

Beyond Conventional Anti-VEGF Therapy:
Reducing the Burden of Treatment and Improving Outcomes in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

PODCAST ACTIVITY: These podcasts provide an up-to-date perspective on improving treatment for patients with neovascular age-related macular degeneration and/or diabetic macular edema who do not achieve optimal outcomes due to insufficient responses to therapy or insufficient adherence. This series of podcasts will elucidate the benefits and limitations of current therapeutic approaches for patients with nAMD or DME, equip participants with strategies for improving the durability of treatment response in patients receiving intravitreal therapies, and provide education on new and emerging treatment strategies.

Learn More & View Event »

Insights to Improve Responses to Immunotherapies: A Simulation Center Approach to Identifying Patients Who May Benefit from Predictive Biomarkers

This simulated activity depicts conversations between an oncologist, a pathologist, and a patient diagnosed with non-small cell lung cancer (NSCLC). You will watch as they engage with each other throughout the various stages of a patient’s journey, from the initial pathologic and oncologic workup at initial presentation to disease recurrence. You will participate in the simulation by answering questions throughout the activity. A brief slide presentations is available within each simulation center activity to enhance your understanding of immunological biomarkers.

Learn More & View Event »

Clinical Pearls for Community-based Oncologists Treating Patients with BRAF-mutated Metastatic Melanoma: Incorporating Novel Sequencing Strategies into Practice

This enduring TeleECHO program will explore key clinical practice insights for management of patients with BRAF-mutated metastatic melanoma. Over the course of this activity there will be discussion of the clinical profiles of frontline combination immuno- and targeted treatment options in BRAF-mutated metastatic melanoma as well as emerging data from clinical trials and real-world studies examining sequencing of these therapies. Interactive case studies will illustrate strategies for treatment selection, mitigation of adverse events, and management considerations for patients with BRAF-mutated metastatic melanoma.

Learn More & View Event »

New Insights on the Diagnosis and Treatment of Nonproliferative Diabetic Retinopathy

This enduring program targets critical issues in nonproliferative diabetic retinopathy (NPDR), including risk for retinopathy development and progression, how early treatment can help prevent progression to vision-threatening complications, and treatment strategies for NPDR. Learn essential elements of assessment and management, as well as clinical trial data on the latest approaches in care, helping to preserve vision in diabetes.

Learn More & View Event »

From “Vicious Cycle” to “Vicious Vortex”: The Evolving Understanding of NCFBE Pathophysiology and Its Implications for Treatment

This case-based virtual activity will cover the pathophysiology, clinical course, and underlying causes of NCFBE; summarize current evidence-based strategies for the diagnosis and treatment of patients with NCFBE; describe how neutrophilic inflammation and high levels of neutrophil serine proteases in patients with NCFBE provide the rationale for targeted treatment; and evaluate clinical data on therapies for NCFBE targeting neutrophilic inflammation neutrophil serine proteases.

Learn More & View Event »

Hope on the Horizon: Emerging Treatment Options for Patients with Retinopathy of Prematurity

This enduring program about retinopathy of prematurity (ROP) targets key concepts about pathophysiology and the role of vascular endothelial growth factor (VEGF), screening, and management for this potentially visually blinding disorder of premature infants. Learn essential elements for recognizing infants at risk, timelines to ROP development, current advances in treatment approaches and critical examination timeframes to help prevent progression as well as complications of advanced disease.

Learn More & View Event »

Improving Outcomes for Patients with Uterine Fibroids and/or Endometriosis: How Does Your Approach Compare with the Experts?

This enduring activity has been designed to help obstetrician gynecologists and other HCPs involved in the care and treatment of patients with uterine fibroids (UF) and/or endometriosis to better support prompt initiation of treatment through early and accurate diagnosis. Key goals of this activity are to justify the need for new treatment options for patients with UFs and endometriosis based on the challenges associated with standard-of-care medical therapies and assess the results of clinical trials supporting the efficacy and safety profiles of newly approved and emerging combination therapies including GnRH antagonists for the long-term management of UFs and endometriosis. Finally, this program will outline individualized management plans for patients with UFs based on new clinical guidance & shared decision-making.

Learn More & View Event »

Pediatric Atopic Dermatitis: Treatment Selection Considerations During the COVID-19 Pandemic

This enduring activity will explore the management of moderate-to-severe atopic dermatitis (AD) in pediatric and adolescent patients. Innovative whiteboard animations will review the mechanism of action of systemic therapies for AD and the impact of COVID-19 on treatment selection. A review of clinical trial data, guideline recommendations, and patient-specific factors that impact management decisions will help clinicians develop personalized treatment plans and improve patient outcomes.

Learn More & View Event »

Addressing Vaccine Hesitancy: Recognizing the Burdens of Infectious Disease and the Value of Preventive Strategies on Global Health

This enduring activity has been designed for global primary care physicians and other members of the multidisciplinary team such as dentists, pharmacists, nurse practitioners, nurses, and allied health care professionals who evaluate patients for vaccination needs. The goal is to help global HCPs define the benefits of vaccination in terms of lives saved and societal medical costs saved; analyze efficacy and safety data with specific vaccines in current approved childhood vaccination schedules, and lastly to describe the history of vaccination and the general manufacturing techniques and clinical trials used in the development of modern vaccines.

Learn More & View Event »

Optimizing Clinical Outcomes with JAK Inhibition in the Management of Inflammatory Bowel Disease: Burden, Unmet Needs, And Novel Therapeutic Options

This CME program provides a comprehensive and up-to-date perspective on the evolving management of patients with inflammatory bowel disease (IBD). We will be discussing unmet needs in the current identification and management of IBD; identifying tools to assist with differential diagnosis, clinical assessment, and selection of effective therapies for IBD; and exploring the underlying pathophysiology of IBD and the role of JAK inhibition in modifying therapeutic outcomes.

Learn More & View Event »

Identifying Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Who May Benefit from Biologic Therapy
The CLEAR Initiative

This enduring program aims to provide clinicians and patients with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for individuals with CRSwNP. Our goal is to provide information that empowers clinicians and patients to speak openly about treatment decisions and improve the standard of care for patients with this challenging disease.

Learn More & View Event »

New Insights on the Diagnosis and Treatment of Age-Related Macular Degeneration

This enduring program targets critical issues in age-related macular degeneration (AMD), including risk for AMD development and progression, how timely diagnosis and treatment can help prevent progression to vision-threatening complications, as well as treatment strategies for AMD. Learn essential elements of assessment and management, as well as clinical trial data on the latest approaches in care, helping to preserve vision in age-macular degeneration.

Learn More & View Event »

A New Day in Type 2 Diabetes in Chronic Kidney Disease: Addressing Risks and Disparities of Care to Optimize Nephrology Care in 2022 — A Nephrology Fellows Program

This educational activity has been designed for nephrology fellows to ensure recognition of CKD risk in patients with T2D, understand novel strategies for modifying CKD risk, and review the risk of other chronic complications of T2D. We aim to evaluate current strategies for the management of CKD in T2D using novel therapeutic agents that modify long-term clinical outcomes, including third-generation mineralocorticoid antagonists; describe current disparities in CKD care in T2D and strategies for integrating novel strategies in practice, including third-generation mineralocorticoid antagonists; and lastly to summarize safety data with novel agents in the management of CKD in T2D, including best practices for managing hyperkalemia with novel mineralocorticoid antagonists.

Learn More & View Event »

Considerations in the Management of Complex Perianal Fistulas in Crohn’s Disease: Burden, Features, and Evolving Management Strategies

The online activity will address the need for novel therapeutic options, including updates on advances in regenerative medicine, for patient with complex perianal fistula associated with Crohn’s disease. Learners will evaluate the current burden of perianal fistula in Crohn’s disease, pathophysiology, and the characteristics of current and emerging mechanisms of therapy.

Learn More & View Event »

Diagnosing and Managing Patients with α-thalassemias: How Does Your Approach Compare with the Experts’?

This online educational activity targets essential elements of the pearls of diagnosis and management of patients with α-thalassemias. Enhance your ability to evaluate the genetic and molecular pathophysiology of the various members of the α-thalassemia family and associated clinical presentations by genotype, as well as the risks for acute and chronic complications. After the timely, accurate diagnosis of α-thalassemia is made, assess the utility of traditional management strategies and the impact of emerging disease-modifying pharmacotherapy for the management of patients with α-thalassemias.

Learn More & View Event »

Beyond A1C: Assessing the Impact of Basal Insulins on Time in Range and Glucose Variability

This CME program has been designed for primary care clinicians, pharmacists, and diabetes educators who care for patients with diabetes as well as patient audiences to increase knowledge of the relationship of glucose variability (GV) and time in range (TIR) to macro- and microvascular outcomes; enhance the ability to explain the importance of continuous glucose monitoring (CGM) and various CGM metrics; and select among basal insulin formulations based on their impacts on TIR and GV.

Learn More & View Event »

New Clinical Guidance on the Use of JAK Inhibitors for Patients with Moderate-to-Severe Rheumatoid Arthritis: How Does Your Approach Compare with the Experts’?

This TeleECHO series has been designed for US-based rheumatologists, nurses, and allied healthcare professionals involved in the management of patients with rheumatoid arthritis (RA), to better interpret data from clinical trials supporting the efficacy, safety, and tolerability of JAK inhibitors (JAKi) with different mechanisms of action in patients with moderate-to-severe RA. This series will help health professionals incorporate new evidence-based management recommendations on the use of JAKi for patients with moderate-to-severe RA into clinical practice, and it also supports patient-centered multidisciplinary team-based approaches to the management of those patients with moderate-to-severe RA.

RELEASED DATE: October 03, 2022
EXPIRATION DATE: October 03, 2023

Learn More & View Event »

Where Are We With Multi-Cancer Early Detection Technologies? Examining the Data, Potential, and Best Practices for Patient Discussions

This enduring activity will help health care professionals better evaluate the potential for multi-cancer early detection technologies to improve cancer detection and therapeutic outcomes in cancer care; analyze the accuracy for application of multicancer early detection technologies and ongoing trials; and choose appropriate patient populations that may be candidates for screening with multicancer early detection technologies and ensure clinicians are ready to discuss the meaning of test results with patients.

RELEASE DATE: October 05,  2022
EXPIRATION DATE: October 05, 2023

Learn More & View Event »

Medical Oncology Management of Non-Metastatic Castration-Resistant Prostate Cancer: Best Practices in the Veteran’s Affairs Administration

This program will discuss the pathogenesis of prostate cancer, the differences in mechanisms of action between the first- and second-generation anti-androgen drugs for prostate cancer, and identifying patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at elevated risk for metastasis, and management in order to reduce risk.

RELEASE DATE: October 06,  2022
EXPIRATION DATE: October 06, 2023

Learn More & View Event »

Addressing Knowledge Gaps in the Diagnostic Process and Outpatient Treatment of COVID-19: Updating Clinicians on Current Best Practices in 2022

This educational activity will explore best practices to ensure prompt and accurate diagnosis of COVID-19 infection and the provision of outpatient care for patients with COVID-19 while incorporating shared decision-making principles and addressing disparities in care.

RELEASED DATE: October 06, 2022
EXPIRATION DATE: October 06, 2023

Learn More & View Event »

Filling an Unmet Medical Need in the Veteran Population: First-Line Treatment of Metastatic NSCLC in Those Without Actionable Molecular Subtypes

This program will discuss tumorigenesis in advanced non-small cell lung cancer (NSCLC) and the mechanism of actions of checkpoint inhibitors, the latest clinical data describing the efficacy and safety of first-line use of PD-1 inhibitor therapy, alone and in combination, and the use of immunotherapy in the first-line treatment of NSCLC with no actionable mutations.

RELEASE DATE: October 07,  2022
EXPIRATION DATE: October 07, 2023

Learn More & View Event »

Using Targeted Treatment Options for the Management of BRAF-mutant Metastatic Colorectal Cancer: How Does Your Approach Compare with the Experts?

This TeleECHO session will explore the management of patients with metastatic colorectal cancer (mCRC) through a short, didactic presentation and interactive case studies. Faculty will review strategies on personalizing the selection of treatment options based on molecular testing; and discuss the management of adverse events with targeted treatments for BRAF V600-mutant mCRC.

RELEASED DATE: October 10, 2022
EXPIRATION DATE: October 10, 2023

Learn More & View Event »

FAMILIAL HYPERCHOLESTEROLEMIA: Making Sense of Disease Mechanisms, Patient Characteristics, and Targeted Treatments

  • Evaluate the panel of agents available for FH and determine their appropriateness based on type of FH, individual patient risk factors, comorbidities, and prior treatment
  • Assess clinical trial evidence looking at long-standing and new therapies for the treatment of patients
    with FH
  • Devise treatment plans that account for genetic aberrations impacting the activity of LDL-Rs in patients with FH

RELEASED DATE: October 13, 2022
EXPIRATION DATE: October 13, 2023

Learn More & View Event »

FAMILIAL HYPERCHOLESTEROLEMIA: Making Sense of Disease Mechanisms, Patient Characteristics, and Targeted Treatments

  • Evaluate the panel of agents available for FH and determine their appropriateness based on type of FH, individual patient risk factors, comorbidities, and prior treatment
  • Assess clinical trial evidence looking at long-standing and new therapies for the treatment of patients
    with FH
  • Devise treatment plans that account for genetic aberrations impacting the activity of LDL-Rs in patients with FH

RELEASED DATE: October 13, 2022
EXPIRATION DATE: October 13, 2023

Learn More & View Event »

FAMILIAL HYPERCHOLESTEROLEMIA: Making Sense of Disease Mechanisms, Patient Characteristics, and Targeted Treatments

  • Evaluate the panel of agents available for FH and determine their appropriateness based on type of FH, individual patient risk factors, comorbidities, and prior treatment
  • Assess clinical trial evidence looking at long-standing and new therapies for the treatment of patients
    with FH
  • Devise treatment plans that account for genetic aberrations impacting the activity of LDL-Rs in patients with FH

RELEASED DATE: October 13, 2022
EXPIRATION DATE: October 13, 2023

Learn More & View Event »

FAMILIAL HYPERCHOLESTEROLEMIA: Making Sense of Disease Mechanisms, Patient Characteristics, and Targeted Treatments

  • Evaluate the panel of agents available for FH and determine their appropriateness based on type of FH, individual patient risk factors, comorbidities, and prior treatment
  • Assess clinical trial evidence looking at long-standing and new therapies for the treatment of patients
    with FH
  • Devise treatment plans that account for genetic aberrations impacting the activity of LDL-Rs in patients with FH

RELEASED DATE: October 13, 2022
EXPIRATION DATE: October 13, 2023

Learn More & View Event »

New Insights on the Diagnosis and Treatment of Retinal Vein Occlusion

This enduring program targets critical issues in retinal vein occlusion (RVO), including risk for RVO, how early treatment can help prevent progression to vision-threatening complications, and treatment strategies for complications of RVO, particularly RVO-related macular edema. Learn essential elements of assessment and management, as well as clinical trial data on the latest approaches in care, helping to preserve vision in retinal vein occlusion.

RELEASE DATE: October 14,  2022
EXPIRATION DATE: October 14, 2023

Learn More & View Event »

The CARES Initiative Making the Move to Mealtime Insulin in Type 2 Diabetes: A Patient-Centered Approach

This online educational program focuses on the latest data on mealtime insulin in patients with type 2 diabetes mellitus. In this program, clinicians will address appropriate treatment intensification strategies in consideration of patient-related factors, the latest clinical data, and key parameters for monitoring clinical response to mealtime insulin. Through this program, clinicians will improve their level of comfort with initiating mealtime insulins to optimize glycemic outcomes, including in underserved populations. Innovative learning strategies will reinforce the latest best practices to support clinician and patient understanding of the latest strategies in glycemic management.

RELEASED DATE: October 14, 2022
EXPIRATION DATE: October 14, 2023

Learn More & View Event »

A New Strategy for the Management of Patients with Psoriasis: The Promise of Selective Tyrosine Kinase 2 Inhibitors

This enduring activity has been designed for healthcare professionals involved in the management of patients with psoriasis to improve knowledge of the function of TYK2 in psoriasis; awareness of clinical profiles of emerging TYK2 inhibitors; their ability to discern the potential place of TYK2 inhibitors in current treatment algorithms; and the adoption of shared decision-making with patients.

RELEASED DATE:  October 25, 2022
EXPIRATION DATE:  October 25, 2023

Learn More & View Event »

Managed Care and Population Health Considerations in Modern Pneumococcal Vaccination: Moving the Needle on Infectious Outcomes

This enduring activity is designed to help HCPs improve their ability to evaluate the risk of pneumococcal infection from a population perspective and consider the importance of various serotypes in managing population health; assess clinical data and specific data with pneumococcal serotypes to determine treatment options in the context of guidelines; and to apply best practices in implementing pneumococcal vaccination schedules to improve health outcomes.

RELEASED DATE: October 26, 2022
EXPIRATION DATE: October 26, 2023

Learn More & View Event »

Reducing Treatment Complexity in Older Adults with T2DM: The Role of Fixed-Ratio GLP-1 Receptor Agonist/Insulin Combinations

This activity will address the challenges faced by clinicians in managing older patients with T2DM. Participants will be equipped with an enhanced ability to apply current guideline recommendations and clinical data to management plans, personalize diabetes treatment for older adults in long-term care facilities and in the community, and gain greater knowledge of the rationale for using fixed ratio combinations of basal insulin and GLP-1 receptor agonists in older adults with T2DM.

RELEASE DATE: October 26,  2022
EXPIRATION DATE: October 26, 2023

Learn More & View Event »

Weight Loss as a Treatment Strategy for Patients with Type 2 Diabetes and Obesity: Practical Strategies for Primary Care Providers

This enduring activity is faculty-led didactic and case-based interactive activities focusing on the management of patients with Type 2 diabetes and obesity. This CME program has been designed to help clinicians recognize overweight/obesity as an important treatment target; utilize guidelines and clinical data on the use of incretin therapies for treatment intensification; and implement shared decision making to better engage patients and personalize care.

RELEASED DATE:  October 27, 2022
EXPIRATION DATE:  October 27, 2023

Learn More & View Event »

Updates in COVID-19 Therapies: What You Need to Know to Optimize Care of Hospitalized Patients in 2022

This activity discusses the care of patients hospitalized with SARS-CoV-2 infection. The program will address the burden of COVID-19 in the US as well as the currently circulating strains. The program is designed to help clinicians integrate the latest treatment guidelines and management strategies for this patient population into their practice. The program will present the results of the latest clinical trials of novel therapies for COVID 19 to inform clinicians’ choice of therapy for patients hospitalized with SARS-CoV-2 to reduce the risk of mortality.

RELEASED DATE: November 1, 2022
EXPIRATION DATE: November 1, 2023

Learn More & View Event »

Optimizing the Management of Patients with Advanced Non-Melanoma Skin Cancers in Community-based Dermatology, Oncology, and Dermato-oncology Practices

This enduring TeleECHO podcast will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas (NMSCs). Over the course of this activity there will be discussion of the data from clinical trials assessing the clinical profiles of new systemic therapies with different mechanisms of action for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation; integrating methods for identifying and managing side effects associated with new systemic therapies for the treatment of patients with advanced NMSCs into routine clinical practice; categorizing the types of patients with unresectable NMSCs who may benefit from new systemic therapies for the treatment of advanced NMSCs; and lastly enhancing patient management including care coordination through participation in interdisciplinary care teams for those with advanced NMSCs failing or not amenable to surgery or radiation.

RELEASED DATE: November 3, 2022
EXPIRATION DATE: November 3, 2023

Learn More & View Event »

CATALYST:
Enhancing Clinical Decision-Making and Optimizing Health Outcomes in Hematologic Malignancies—Focus on CLL and AML

  • Summarize the relevance of molecular markers and genetic data relevant to selection of therapy in CLL or AML
  • Review relevant treatment best practices in both newly diagnosed and relapsed/refractory AML in consideration of disease- and patient-specific factors to inform shared decision-making
  • Evaluate potential adverse events associated CLL and AML therapies to implement appropriate monitoring and counseling

RELEASED DATE: November 4, 2022
EXPIRATION DATE: November 4, 2023

Learn More & View Event »

The Role of the Mohs Surgeon on Interdisciplinary Care Teams for Patients with Advanced Non-Melanoma Skin Cancers

This enduring activity investigates the critical role of systemic therapy, including targeted treatment and immunotherapy, in patients with advanced non-melanoma skin cancers (NMSCs) who fail or are ineligible for surgical or radiation therapy. Learn more about factors that can help determine when systemic therapy is appropriate, available, and emerging systemic treatment options, and elements of multidisciplinary care to enhance your management approach in NMSC.

RELEASED DATE: November 7, 2022
EXPIRATION DATE: November 7, 2023

Learn More & View Event »

Vision RELIEF: Navigating Anti-VEGF Treatment Options to Optimize Treatment Individualization

This Immersive Simulation Experience in diabetic retinopathy (DR), neovascular age-related macular degeneration (nAMD) and retinal vein occlusion (RVO) allows learners to engage in clinical decision-making to individualize treatment with anti-vascular endothelial growth factor (anti-VEGF) therapies. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care, including identifying eyes that may benefit from anti-VEGF treatment, incorporating assessment of efficacy and safety data into treatment decisions, and strategizing changes in treatment approach to achieve optimal outcomes.

RELEASED DATE: November 18, 2022
EXPIRATION DATE: November 18, 2023

Learn More & View Event »

Updates in the PIK3CA-Related Overgrowth Spectrum (PROS) Disorders: Updates in Diagnosis, Targeted Therapy, and Treatment

This enduring activity has been designed to address the latest therapy, guidelines, and clinical trials in the management of PIK3CA-related overgrowth spectrum (PROS). Med Learning Group aims to enhance healthcare professionals’ ability to evaluate best practices in the diagnosis of PROS, including phenotypic variability, disease impacts, and challenges in genetic testing; to summarize the multi-systemic burden of PROS on quality of life and evaluate same when considering an evidence-based treatment plan; and finally, to analyze the safety and efficacy of approved therapy for the management of PROS as well as opportunities for clinical trial enrollment.

RELEASED DATE: November 22, 2022
EXPIRATION DATE: November 22, 2023

Learn More & View Event »

Therapeutic Perspectives in Lymphoma Management: Current Considerations With Novel Bispecific Antibodies

STRIVE aims to create an initiative that HCPs can access to better define novel targets in the management of B-cell lymphomas, including bispecific antibodies and combinations under evaluation; summarize outcomes of key trials in B-cell lymphoma management, including diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma; and lastly to evaluate potential adverse events associated with novel therapies and best practices for management of adverse events in a multidisciplinary manner.

RELEASED DATE: November 22, 2022
EXPIRATION DATE: November 22, 2023

Learn More & View Event »

Evaluating the Role of Type 2 Inflammation in Eosinophilic Esophagitis: Burden, Unmet Needs, and Contemporary Considerations in Targeted Biologic Therapy

The RESTORE enduring will focus on the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis (EoE). Patients with EoE are often diagnosed after symptom onset, leading to greater chronic inflammation, and treatment plans are frequently not tailored to individual needs. This activity is intended to help healthcare professionals diagnose EoE earlier and provide individualized treatment based on guidelines, recent clinical data, and patient characteristics.

RELEASED DATE: November 29, 2022
EXPIRATION DATE: November 29, 2023

Learn More & View Event »

Updates in Therapies Counteracting Tissue Factor Pathway Inhibition in Patients with Hemophilia: Recognizing Developments and Clinical Context in Therapy

With a focus on emerging anti-tissue factor pathway inhibition therapies, this enduring activity addresses developments in hemophilia management which are an important priority for clinicians seeking to improve clinical outcomes in their patients with hemophilia A and B, including patients with evidence of inhibitors to conventional factor VIII and factor IX replacement therapies.

RELEASED DATE:  November 30, 2022
EXPIRATION DATE:  November 30, 2023

Learn More & View Event »

Recent Advances in the Management of Patients with Advanced Hepatocellular Carcinoma: How Does Your Approach Compare with the Experts’?

This case-based enduring virtual activity is designed to improve clinicians’ ability to use an evidence-based approach for the selection of therapies for the treatment of patients with advanced hepatocellular carcinoma (HCC); adopt protocols to minimize the harms attributable to the use of guideline-recommended systemic therapies; in addition to considering the biomarker status of patients with advanced HCC when developing management strategies.

RELEASED DATE: December 1, 2022
EXPIRATION DATE: December 1, 2023

Learn More & View Event »

Optimizing the Management of Patients with Advanced Non-Melanoma Skin Cancers in Community-based Dermatology, Oncology, and Dermato-oncology Practices

This enduring TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas (NMSCs). Over the course of this activity there will be discussion of the data from clinical trials assessing the clinical profiles of new systemic therapies with different mechanisms of action for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation; integrating methods for identifying and managing side effects associated with new systemic therapies for the treatment of patients with advanced NMSCs into routine clinical practice; categorizing the types of patients with unresectable NMSCs who may benefit from new systemic therapies for the treatment of advanced NMSCs; and lastly enhancing patient management including care coordination through participation in interdisciplinary care teams for those with advanced NMSCs failing or not amenable to surgery or radiation.

RELEASED DATE: December 5, 2022
EXPIRATION DATE: December 5,, 2023

Learn More & View Event »
Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.